SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-219636
Filing Date
2024-09-16
Accepted
2024-09-16 16:30:56
Documents
11
Period of Report
2024-10-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d48307ddef14a.htm DEF 14A 201828
2 GRAPHIC g48307dsp43b.jpg GRAPHIC 97501
3 GRAPHIC g48307dsp43d.jpg GRAPHIC 3792
4 GRAPHIC g48307dsp43e.jpg GRAPHIC 3294
5 GRAPHIC g48307dsp44.jpg GRAPHIC 11650
6 GRAPHIC g48307dsp44a.jpg GRAPHIC 1259
7 GRAPHIC g48307g01t02.jpg GRAPHIC 46629
8 GRAPHIC g48307g02p05.jpg GRAPHIC 71840
9 GRAPHIC g48307sp1.jpg GRAPHIC 10450
10 GRAPHIC g48307sp1a.jpg GRAPHIC 1729
11 GRAPHIC g48307sp1b.jpg GRAPHIC 2073
  Complete submission text file 0001193125-24-219636.txt   549221
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39334 | Film No.: 241301456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)